DAVID G JOHNSON to Skin Neoplasms
This is a "connection" page, showing publications DAVID G JOHNSON has written about Skin Neoplasms.
Connection Strength
0.443
-
E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway. Oncogene. 2006 Feb 09; 25(6):867-76.
Score: 0.086
-
Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model. Cancer Res. 2002 Jun 01; 62(11):3276-81.
Score: 0.066
-
Myc lacks E2F1's ability to suppress skin carcinogenesis. Oncogene. 2001 Aug 30; 20(38):5341-9.
Score: 0.063
-
Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53. Proc Natl Acad Sci U S A. 1998 Jul 21; 95(15):8858-63.
Score: 0.051
-
Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development. Oncogene. 1998 Mar 12; 16(10):1267-76.
Score: 0.050
-
Slug expression in mouse skin and skin tumors is not regulated by p53. J Invest Dermatol. 2014 Feb; 134(2):566-568.
Score: 0.036
-
Enhanced skin carcinogenesis and lack of thymus hyperplasia in transgenic mice expressing human cyclin D1b (CCND1b). Mol Carcinog. 2009 Jun; 48(6):508-16.
Score: 0.027
-
Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues. Mol Cell Biol. 2004 Sep; 24(17):7538-47.
Score: 0.019
-
Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice. Nat Cell Biol. 2003 Jul; 5(7):655-60.
Score: 0.018
-
E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model. Mol Cell Biol. 1999 Sep; 19(9):6408-14.
Score: 0.014
-
Deregulated expression of cell-cycle proteins during premalignant progression in SENCAR mouse skin. Oncogene. 1998 Oct 29; 17(17):2251-8.
Score: 0.013